Prelude Therapeutics secures $60M from Incyte option deal
Go back to Prelude Therapeutics secures $60M from Incyte option deal| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 121.86 -1.42 (1.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.28 | 52 Week High | $118.49 | |||
| Open | $124.35 | 52 Week Low | $55.00 | |||
| Day High | $124.35 | P/E | N/A | |||
| Day Low | $121.61 | EPS | $-0.56 | |||
| Volume | 900,958 | |||||
| (NASDAQ: PRLD) | Delayed: 4.63 -0.04 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.67 | 52 Week High | $ | |||
| Open | $4.72 | 52 Week Low | $ | |||
| Day High | $4.75 | P/E | N/A | |||
| Day Low | $4.56 | EPS | $ | |||
| Volume | 421,300 | |||||
